Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
Clinical trial NCT05164120 · COMPLETED
Trial details
- NCT number
- NCT05164120
- Sponsor
- MedStar Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2022-07-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.